118 related articles for article (PubMed ID: 29175021)
1. PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma.
Zeleniak AE; Huang W; Fishel ML; Hill R
Neoplasia; 2018 Jan; 20(1):12-24. PubMed ID: 29175021
[TBL] [Abstract][Full Text] [Related]
2. The mechanisms behind the dual role of long non-coding RNA (lncRNA) metastasis suppressor-1 in human tumors: Shedding light on the molecular mechanisms.
Abdullaev B; Alsaab HO; Hjazi A; Alkhafaji AT; Alawadi AH; Hamzah HF
Pathol Res Pract; 2024 Apr; 256():155189. PubMed ID: 38452581
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target.
Franses JW; Philipp J; Missios P; Bhan I; Liu A; Yashaswini C; Tai E; Zhu H; Ligorio M; Nicholson B; Tassoni EM; Desai N; Kulkarni AS; Szabolcs A; Hong TS; Liss AS; Fernandez-Del Castillo C; Ryan DP; Maheswaran S; Haber DA; Daley GQ; Ting DT
Nat Commun; 2020 Jul; 11(1):3303. PubMed ID: 32620742
[TBL] [Abstract][Full Text] [Related]
4. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia.
Spadafora V; Pryce BR; Oles A; Talbert EE; Romeo M; Vaena S; Berto S; Ostrowski MC; Wang DJ; Guttridge DC
BMC Cancer; 2024 Apr; 24(1):414. PubMed ID: 38570770
[TBL] [Abstract][Full Text] [Related]
5. Familial Pancreatic Ductal Adenocarcinoma.
Diaz KE; Lucas AL
Am J Pathol; 2019 Jan; 189(1):36-43. PubMed ID: 30558720
[TBL] [Abstract][Full Text] [Related]
6. A potential new biomarker in HNSCC: metastasis suppressor protein 1 (MTSS1).
Klein M; Wermker K; Rashad A; Fischer HJ; Jonigk DD; Hölzle F; Cacchi C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Apr; 137(4):391-401. PubMed ID: 38443233
[TBL] [Abstract][Full Text] [Related]
7. CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.
Samain R; Maiques O; Monger J; Lam H; Candido J; George S; Ferrari N; KohIhammer L; Lunetto S; Varela A; Orgaz JL; Vilardell F; Olsina JJ; Matias-Guiu X; Sarker D; Biddle A; Balkwill FR; Eyles J; Wilkinson RW; Kocher HM; Calvo F; Wells CM; Sanz-Moreno V
Sci Adv; 2023 Oct; 9(42):eadi0244. PubMed ID: 37851808
[TBL] [Abstract][Full Text] [Related]
8. The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic ductal adenocarcinoma cells.
Nguyen A; Mustafa AM; Leydecker AK; Halilovic M; Murr J; Butter F; Krämer OH
Cell Commun Signal; 2024 Apr; 22(1):217. PubMed ID: 38570831
[TBL] [Abstract][Full Text] [Related]
9. X-aptamers targeting Thy-1 membrane glycoprotein in pancreatic ductal adenocarcinoma.
Wang H; Li X; Lai LA; Brentnall TA; Dawson DW; Kelly KA; Chen R; Pan S
Biochimie; 2021 Feb; 181():25-33. PubMed ID: 33242496
[TBL] [Abstract][Full Text] [Related]
10. MTSS1 curtails lung adenocarcinoma immune evasion by promoting AIP4-mediated PD-L1 monoubiquitination and lysosomal degradation.
Wang Y; Jia Z; Liang C; He Y; Cong M; Wu Q; Tian P; He D; Miao X; Sun B; Yin Y; Peng C; Yao F; Fu D; Liang Y; Zhang P; Xiong H; Hu G
Cell Discov; 2023 Feb; 9(1):20. PubMed ID: 36810288
[TBL] [Abstract][Full Text] [Related]
11. PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation.
Chang TM; Chu PY; Lin HY; Huang KW; Hung WC; Shan YS; Chen LT; Tsai HJ
J Biomed Sci; 2022 Nov; 29(1):92. PubMed ID: 36336681
[TBL] [Abstract][Full Text] [Related]
12. MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination.
Cong M; Wang Y; Yang Y; Lian C; Zhuang X; Li X; Zhang P; Liu Y; Tang J; Yang Q; Zhang X; Xiong H; Hu R; Hu G
Nat Cancer; 2020 Feb; 1(2):222-234. PubMed ID: 35122005
[TBL] [Abstract][Full Text] [Related]
13. Metastasis suppressor 1 controls osteoblast differentiation and bone homeostasis through regulating Src-Wnt/β-catenin signaling.
Chen M; Shan L; Gan Y; Tian L; Zhou J; Zhu E; Yuan H; Li X; Wang B
Cell Mol Life Sci; 2022 Jan; 79(2):107. PubMed ID: 35094173
[TBL] [Abstract][Full Text] [Related]
14. The Novel Phosphatase Domain Mutations Q171R and Y65S Switch PTEN from Tumor Suppressor to Oncogene.
Garrido JAMG; Alcantara KMM; Danac JMC; Serrano FEC; Cutiongco-de la Paz EM; Garcia RL
Cells; 2021 Dec; 10(12):. PubMed ID: 34943931
[TBL] [Abstract][Full Text] [Related]
15. Stable Isotopes for Tracing Cardiac Metabolism in Diseases.
Karlstaedt A
Front Cardiovasc Med; 2021; 8():734364. PubMed ID: 34859064
[TBL] [Abstract][Full Text] [Related]
16. MTSS1 inhibits metastatic potential and induces G2/M phase cell cycle arrest in gastric cancer.
Liu K; Jiao XD; Hao JL; Qin BD; Wu Y; Chen W; Liu J; He X; Zang YS
Onco Targets Ther; 2019; 12():5143-5152. PubMed ID: 31303767
[No Abstract] [Full Text] [Related]
17. Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC.
Alhothali M; Mathew M; Iyer G; Lawrence HR; Yang S; Chellappan S; Padmanabhan J
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100813
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma.
Ruckert MT; de Andrade PV; Santos VS; Silveira VS
Cell Mol Life Sci; 2019 Jul; 76(13):2571-2592. PubMed ID: 30982078
[TBL] [Abstract][Full Text] [Related]
19. Computational analysis of the evolutionarily conserved Missing In Metastasis/Metastasis Suppressor 1 gene predicts novel interactions, regulatory regions and transcriptional control.
Petrov P; Sarapulov AV; Eöry L; Scielzo C; Scarfò L; Smith J; Burt DW; Mattila PK
Sci Rep; 2019 Mar; 9(1):4155. PubMed ID: 30858428
[TBL] [Abstract][Full Text] [Related]
20. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity.
Si W; Liu X; Wei R; Zhang Y; Zhao Y; Cui L; Hong T
Cell Death Dis; 2019 Feb; 10(3):206. PubMed ID: 30814496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
